Analytic Investors’s Imperva, Inc. IMPV Stock Holding History

Analytic Investors’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-26,768	Closed	-$1.7M	–	712
2015 Q4	$1.7M	Sell	26,768 -6,321	-19%	-$430K	0.02%	319
2015 Q3	$2.17M	Buy	33,089 +26,073	+372%	+$1.73M	0.03%	279
2015 Q2	$475K	Buy	+7,016	New	+$387K	0.01%	462

Other funds holding IMPV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Analytic Investors's IMPV Position: Q1 2016 in Review

Analytic Investors sold out of Imperva, Inc. (IMPV) in Q1 2016, closing a stake of 26,768 shares — an estimated $1.7M sold.

Analytic Investors first reported a position in IMPV in Q2 2015 and held it in 3 quarters. The position peaked at $2.17M in Q3 2015. 160 funds tracked by Wall St. Rank hold IMPV as of Q1 2016.

Analytic Investors reported no remaining Imperva, Inc. position as of Q1 2016 after selling out during the quarter.
Analytic Investors sold 26,768 Imperva, Inc. shares in Q1 2016, an estimated $1.7M.
Analytic Investors first reported a position in Imperva, Inc. in Q2 2015 and held it in 3 quarters.
Analytic Investors's Imperva, Inc. position peaked at $2.17M in Q3 2015.
160 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2016.

Based on Analytic Investors's 13F filing for Q1 2016, filed 20 May 2016.